parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.01 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including microglia; strongest in kupffer cells	0.75
chemistry Open Targets	hard to drug	0.00
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	3 Parkinson's papers of 642	0.82
pathways Reactome	in no curated pathway	0.00

No case: the score is under the bar. Receipt 11302

receipt 11309: ABI3 in dopamine neurons, braak

power: full sample -0.50 (p 0.035, n 18), 95% CI -0.78 to -0.04. the interval excludes zero: something may be there, smaller than a half can see.
confounder: adjusted for sex: -0.52 (p 0.027, n 18). holds up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.55 (p 0.018, n 18). not the mix.
skeptic: leave-one-out range -0.68 to -0.43, sign flips 0; without severely affected donors -0.50 (p 0.035, n 18). robust.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ABI3 in dopamine neurons.

case closed: nothing better to follow up.

receipt 11308: ABI3 in microglia, braak

power: full sample -0.35 (p 0.156, n 18), 95% CI -0.70 to +0.14. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.43 (p 0.072, n 18). does not hold up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.30 (p 0.232, n 18). could be the mix.
skeptic: leave-one-out range -0.51 to -0.27, sign flips 0; without severely affected donors -0.35 (p 0.156, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ABI3 in microglia.

case closed: nothing better to follow up.

loading the receipts